Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Array BioPharma, Inc.

http://www.arraybiopharma.com

Latest From Array BioPharma, Inc.

Pfizer Embraces Biotech-Like Speed To Advance BCMA Bispecific

Chris Boshoff, Pfizer Oncology chief development officer, said lessons from the rapid pace of the company’s COVID-19 vaccine program are being applied to elranatamab and other cancer therapies.

Research and Development Strategies Business Strategies

Pazdur Unplugged: US FDA’s “Project Livin’ Label” Shows Back Story On Cancer Drug Approvals

Latest Oncology Center of Excellence initiative is officially a CME effort designed to encourage practitioners to make full use of the information in the approved drug labeling. It is also a surprisingly effective way to explain drug approvals in a flattering light for regulators and sponsors.

Cancer Approvals

One To Watch: Ruling On AZ’s First-In-Class Anemia Drug Roxadustat Expected Shortly

AstraZeneca is in pole position to open up the HIF-PH inhibitor market – but GSK has a rival in the wings.

Commercial Companies

Medicare Bundled Payment Policies Could Cut Amgen’s Parsabiv Sales By 50%

Amgen looks forward to working with CMS and Congress to shape Medicare reimbursement policies in a way that better ensures access.

Medicare Reimbursement
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
UsernamePublicRestriction

Register